Currently, there are no approved treatments specifically for autism spectrum disorder (ASD). That’s why we need your help. We are enrolling adolescents and young adults with ASD ages 13 through 35 to participate in a study at SARRC. The purpose of this research is to determine the effectiveness of an investigational medication in improving the most common behavioral symptoms of ASD.
- This study is a double-blind trial meaning that half of the participants receive the active medication and half receive a tablet with no active medication.
- Over 16 weeks, there will be 8 study visits at SARRC’s Research Center. Adults and caregivers will receive reimbursement for their time and travel. Study-related medical exams, ASD assessments, and the study medication will be provided at no cost to families.
- Eye-tracking and other biometric data will be collected which may provide a robust way to determine the possible effectiveness of the investigational medication.
- Parents or caregivers will track several behaviors through an online portal that can be easily accessed through their smartphone or computer.
Participation includes:
- (8) in-person study visits over 16 weeks to SARRC's campus*
- Close monitoring of health and behavior
- Reimbursement for participation and travel to SARRC's campus**
*SARRC has strict COVID-19 safety procedures in place for in-office visits to ensure families and clients are safe while visiting our center.
**We provide additional compensation for travel beyond 50 miles.
Enrollment
To learn more about the Janssen study or to enroll, contact a member of our team at 602.606.9888 or contact us online.
Research at SARRC
SARRC’s research program brings together scientists, research methods, and stakeholders to gain a better understanding of possible causes of autism, identify better treatments, and educate others about how to improve the quality of life for those impacted by ASD and their families. Learn more »